Acne Treatment Guidelines

Initial Assessment and Treatment

The American Academy of Dermatology recommends assessing acne severity using the Physician Global Assessment (PGA) scale to classify as mild, moderate, or severe, and evaluating for scarring, post-inflammatory dyspigmentation, and psychosocial impact, as these factors warrant more aggressive treatment regardless of lesion count 1, 2
Patients with any scarring or significant psychosocial burden should be considered candidates for more intensive therapy, potentially including isotretinoin, according to the American Academy of Dermatology 1, 2

For mild acne, the American Academy of Dermatology recommends first-line treatment with topical retinoid + benzoyl peroxide, with adapalene 0.1% gel as the preferred retinoid, applied once nightly to completely dry skin, and benzoyl peroxide 2.5-5% gel applied once daily in the morning 1, 2, 3
For moderate acne, the American Academy of Dermatology recommends first-line treatment with fixed-dose combination topical retinoid + benzoyl peroxide, and adding topical antibiotic (clindamycin 1% or erythromycin 3%) combined with benzoyl peroxide for inflammatory lesions 1, 2
For moderate-to-severe inflammatory acne, the American Academy of Dermatology recommends first-line treatment with oral antibiotics + topical retinoid + benzoyl peroxide (triple therapy), with doxycycline 100 mg once daily as the preferred oral antibiotic, and limiting systemic antibiotics to 3-4 months maximum to minimize bacterial resistance 1, 2

The American Academy of Dermatology conditionally recommends combined oral contraceptives for female patients, which can reduce inflammatory lesions by 62% at 6 months, and spironolactone 25-200 mg daily for hormonal acne patterns, premenstrual flares, or those who cannot tolerate oral antibiotics 1, 2

The American Academy of Dermatology recommends intralesional corticosteroids, such as triamcinolone acetonide 10 mg/mL, for large, painful nodules to provide rapid pain relief within 48-72 hours 1, 2

The American Academy of Dermatology recommends continuing topical retinoid monotherapy indefinitely after achieving clearance to prevent recurrence, and benzoyl peroxide can also be continued as maintenance 1, 3

The American Academy of Dermatology advises against using topical or oral antibiotics as monotherapy, as resistance develops rapidly without concurrent benzoyl peroxide, and against extending oral antibiotics beyond 3-4 months without re-evaluation, as this dramatically increases resistance risk 1, 2, 3

The American Academy of Dermatology guidelines do not include topical corticosteroids for acne treatment at any severity level, as they can induce or exacerbate acne, with betamethasone causing acne in three subjects in vitiligo treatment studies 4
Topical steroids are not recommended for acne treatment due to the risk of steroid-induced acne, and their use can worsen the condition, as evidenced by studies on vitiligo treatment where topical steroids caused adverse effects 5

Intralesional triamcinolone acetonide 10 mg/mL can be used for individual large, painful nodules to provide rapid pain relief within 48-72 hours, but this is not a topical application for general acne treatment, and its use is limited to specific lesions 4
The use of topical steroids for other dermatologic conditions, such as eczema, psoriasis, or bullous pemphigoid, is not relevant to acne management and can lead to fundamental treatment errors 5